This invention relates generally to microfluidic devices for the rapid detection of analytes in a fluid.
Point-of-care (POC) diagnostics are inherently attractive in many resource-limited settings where the healthcare, transportation, and distribution infrastructure is underdeveloped and underfunded. The main advantage of a POC diagnostic is the ability to diagnose disease without the support of a laboratory infrastructure; this increases access, removes the need for sample transport, and shortens turnaround times from weeks (or months) to hours. As a result, more patients are effectively diagnosed, enabling faster and more complete treatment. Although commercial paper-based sensors have been around for about 25 years (e.g., pregnancy test and glucose test strips), few paper POC devices have been successfully commercialized. Such failure to produce trustworthy paper POC devices is a combination of many factors, including poor limits of detection (LOD), high non-specific adsorption (NSA), unstable reagents, long analysis time, complex user-technology interface, detection method, and poor sensitivity. There is a need for paper point-of-care (POC) devices that are cheap, user friendly, robust, sensitive, and portable. Such devices pose an effective solution to the existing economic and healthcare accessibility problems in underdeveloped countries, as well as the growing trend in more affluent societies to become better informed in terms of its health.
Most paper-based analytical devices rely on capillary flow to control both direction and rate of fluid flow though the device. While capillary driven-flow is advantageous in many regards, the presence of the cellulose matrix introduces several difficulties such as low rates of convective mass transfer, significant non-specific adsorption due to the high surface area of the cellulose fibers, and a size restriction on the mobility of objects within cellulose matrix due to the size-exclusion properties of paper. Microfluidic devices containing hollow channels provide a fluid flow path that is unencumbered by a cellulose matrix. However, without a cellulose matrix defining a fluid flow path, there is no driving force for fluid flow through the hollow hydrophobic channel. In such cases, pressure must be applied externally to drive fluid flow through the hollow hydrophobic channel (e.g., using a syringe pump). As a consequence, existing hollow channel microfluidic devices are not well suited for many POC applications.
It is an object of this invention to provide microfluidic devices that can induce fast fluid flow through a channel under low applied pressure.
It is also an object of this invention, to provide paper-base microfluidic devices that have a quantitative read out, low limits of detection, and low cost of instrumentation.
Provided herein are microfluidic devices that can be configured to induce fast fluid flow through a hollow microfluidic channel under low applied pressure. The microfluidic devices can comprise a fluid inlet, a fluid outlet, and a hollow channel fluidly connecting the fluid inlet and the fluid outlet, so as to form a fluid flow path from the fluid inlet to the fluid outlet.
The hollow channel can comprise a fluid flow path defined by a floor, two or more side walls, and optionally a ceiling. Together, the floor, the two or more side walls, and the ceiling, when present, define a conduit or void space through which fluid (e.g., an aqueous solution) can flow during device operation. One or more of the interior surfaces of the hollow channel (e.g., the floor, a side walls, the ceiling, or a combination thereof) can comprise a hydrophilic material. The hydrophilic material can be porous hydrophilic material, such as paper. The hydrophilic material can drive fluid flow through the hollow channel, allowing for fast fluid flow through the hollow microfluidic channel under low applied pressure.
The microfluidic devices can be used in analytical applications, for example, to assay a fluid sample for the presence of one or more analytes. In some cases, the microfluidic device can further include an assay reagent that facilitates the detection, identification, and/or quantification of an analyte present in the fluid sample. In some cases, the microfluidic device can further include a detection device, for example, an image scanner, a camera, a fluorometer, a spectrometer, or an electroanalytical device which can be used to detect and/or measure the analyte, the assay reagent, a substance indicative of the analyte, or a combination thereof. In certain embodiments, the microfluidic device can include one or more electrodes in electrochemical contact with the hollow channel that can be used to detect and/or measure the analyte, the assay reagent, a substance indicative of the analyte using conventional electroanalytical methods. In some embodiments, the electrode can be a bulk conductive electrode.
The devices described herein can be inexpensive, user friendly (they employ electrochemical detection without any washing steps), sensitive, portable, robust, efficient, rapid (completion of analysis in minutes), and can detect low concentrations of analytes in a fluid sample. The microfluidic devices can exhibit electrochemical and hydrodynamic behavior similar to traditional glass and plastic microfluidic electrochemical devices. As such, the devices are well suited for use in numerous sensing applications, for example, quantitative, low limit-of-detection, and/or point-of-care paper analytical devices.
The devices and methods described herein may be understood more readily by reference to the following detailed description of specific aspects of the disclosed subject matter, figures and the examples included therein.
Before the present devices and methods are disclosed and described, it is to be understood that the aspects described below are not intended to be limiting in scope by the specific devices and methods described herein, which are intended as illustrations. Various modifications of the devices and methods in addition to those shown and described herein are intended to fall within the scope of that described herein. Further, while only certain representative devices and method steps disclosed herein are specifically described, other combinations of the devices and method steps also are intended to fall within the scope of that described herein, even if not specifically recited. Thus, a combination of steps, elements, components, or constituents may be explicitly mentioned herein or less, however, other combinations of steps, elements, components, and constituents are included, even though not explicitly stated.
The term “comprising” and variations thereof as used herein is used synonymously with the term “including” and variations thereof and are open, non-limiting terms. Although the terms “comprising” and “including” have been used herein to describe various examples, the terms “consisting essentially of” and “consisting of” can be used in place of “comprising” and “including” to provide for more specific examples of the invention and are also disclosed. Other than in the examples, or where otherwise noted, all numbers expressing quantities of ingredients, reaction conditions, and so forth used in the specification and claims are to be understood at the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, to be construed in light of the number of significant digits and ordinary rounding approaches.
As used in the description and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a composition” includes mixtures of two or more such compositions, reference to “an agent” includes mixtures of two or more such agents, reference to “the component” includes mixtures of two or more such components, and the like.
“Optional” or “optionally” means that the subsequently described event or circumstance can or cannot occur, and that the description includes instances where the event or circumstance occurs and instances where it does not.
“Multiple” or “plurality” as used herein, is defined as two or more than two.
Also, throughout this specification, various publications are referenced. The disclosures of these publications in their entireties are hereby incorporated by reference into this application in order to more fully describe the state of the art to which the disclosed matter pertains. The references disclosed are also individually and specifically incorporated by reference herein for the material contained in them that is discussed in the sentence in which the reference is relied upon.
Devices
Provided herein are microfluidic devices configured to induce fast fluid flow through a hollow microfluidic channel under low applied pressure. The microfluidic devices can comprise a fluid inlet, a fluid outlet, and a hollow channel fluidly connecting the fluid inlet and the fluid outlet, so as to form a fluid flow path from the fluid inlet to the fluid outlet.
The hollow channel can comprise a fluid flow path defined by a floor, two or more side walls, and optionally a ceiling. Together, the floor, the two or more side walls, and the ceiling, when present, define a conduit or void space through which fluid (e.g., an aqueous solution) can flow during device operation. The interior of the hollow channel through which fluid flows contains one or more regions along the length of the fluid flow path that are substantially free of a matrix material (e.g., that are substantially free of a porous solid such as paper or cellulose through which fluid flows during device operation). In some embodiments, the entire length of the hollow channel can be substantially free of matrix material.
The floor, the two or more side walls, and/or optionally the ceiling can be substantially impermeable to fluid flow, so as to form boundaries that define a path for fluid flow through the hollow channel. For example, the floor, the two or more side walls, and/or optionally the ceiling can be substantially hydrophobic, so as to form boundaries that restrict fluid flow within the hollow channel, thereby defining a path for the flow of an aqueous solution through the hollow channel.
One or more of the interior surfaces of the hollow channel (e.g., the floor, a side walls, the ceiling, or a combination thereof) can comprise a hydrophilic material. The hydrophilic material can comprise a portion of one or more of the interior surfaces of the hollow channel (e.g., a portion of the floor, a portion of a side wall, a portion of the ceiling, or a combination thereof). Alternatively, the hydrophilic material can comprise the entirety of one or more of the interior surfaces of the hollow channel (e.g., the entirety of the floor, the entirety of a side wall, the entirety of the ceiling, or a combination thereof). The hydrophilic material can be porous. The hydrophilic material can drive fluid flow through the hollow channel, allowing for fast fluid flow through the hollow microfluidic channel under low applied pressure.
The dimensions of the hollow channel can be varied so as to provide a device having performance characteristics desired for a particular application. The hollow channel can be fabricated so as to have a variety of cross-sectional dimensions. For example, in some embodiments, the hollow channels can have a substantially square or rectangular cross-sectional shape. Though referred to herein as “microfluidic devices,” the devices described herein can include hollow channels having dimensions (e.g., width and/or height) on the micron or millimeter scale.
The hollow channel can have any suitable width, provided that the channel width is compatible with device function. In some embodiments, the hollow channel can have a width (e.g., defined as the distance between two side walls of the hollow channel) of about 50 mm or less (e.g., about 45 mm or less, about 40 mm or less, about 35 mm or less, about 30 mm or less, about 25 mm or less, about 20 mm or less, about 15 mm or less, about 10 mm or less, about 7.5 mm or less, about 5 mm or less, about 2.5 mm or less, about 2 mm or less, about 1.5 mm or less, about 1 mm or less, or about 0.5 mm or less). In some embodiments, the hollow channel can have a width of at least about 0.1 mm (e.g., at least about 0.5 mm, at least about 1 mm, at least about 1.5 mm, at least about 2 mm, at least about 2.5 mm, at least about 5 mm, at least about 7.5 mm, at least about 10 mm, at least about 15 mm, at least about 20 mm, at least about 25 mm, at least about 30 mm, at least about 35 mm, at least about 40 mm, or at least about 45 mm).
The hollow channel can have a width that ranges from any of the minimum dimensions to any of the maximum dimensions described above. For example, the hollow channel can have a width that ranges from about 0.1 mm to about 50 mm (e.g., from about 0.1 mm to about 25 mm, or from about 0.1 mm to about 10 mm). In some embodiments, the hollow channel can have widths of greater than 50 mm (e.g., as large as 1 cm).
In some embodiments, the hollow channel can have a height (e.g., defined as the distance between the floor and the ceiling of the hollow channel) of at least about 10 microns (e.g., at least about 25 microns, at least about 50 microns, at least about 75 microns, at least about 100 microns, at least about 150 microns, at least about 200 microns, at least about 300 microns, at least about 400 microns, at least about 500 microns, at least about 600 microns, or at least about 700 microns). In some embodiments, the hollow channel can have a height of about 750 microns or less (e.g., about 700 microns or less, about 600 microns or less, about 500 microns or less, about 300 microns or less, about 250 microns or less, about 200 microns or less, about 150 microns or less, about 100 microns or less, about 90 microns or less, about 80 microns or less, about 400 microns or less, about 300 microns or less, about 200 microns or less, about 150 microns or less, about 100 microns or less, about 75 microns or less, about 50 microns or less, or about 25 microns or less).
The hollow channel can have a height that ranges from any of the minimum dimensions to any of the maximum dimensions described above. For example, the hollow channel can have a height that ranges from about 10 microns to about 750 microns (e.g., from about 10 microns to about 500 microns, from about 10 microns to about 300 microns, from about 25 microns to about 300 microns, or from about 10 microns to about 75 microns).
The length of the hollow channel can be selected in view of a number of the overall device design and other operational considerations. In some embodiments, the hollow channel have a length of at least about 0.1 cm (e.g., at least about 0.2 cm, at least about 0.3 cm, at least about 0.4 cm, at least about 0.5 cm, at least about 0.6 cm, at least about 0.7 cm, at least about 0.8 cm, at least about 0.9 cm, at least about 1 cm, at least about 2 cm, at least about 2.5 cm, at least about 3 cm, at least about 4 cm, at least about 5 cm, or longer). The hollow channel in the microfluidic device can be substantially linear in shape, or they can possess one or more non-linear regions (e.g., a curved region, a spiral region, an angular region, serpentine, or combinations thereof) along the length of their fluid flow path. If desired for particular applications, three-dimensional networks of hollow channels can be fabricated.
The microfluidic devices described can be fabricated from any suitable material or combination of materials. In some embodiments, the devices are paper-based microfluidic devices. Paper-based microfluidic devices are microfluidic devices wherein the hollow channel for fluid flow is formed within one or more layers of a paper substrate material. An appropriate paper substrate material can be selected in view of the design of the device, the intended applications for the device, and considerations regarding device manufacture.
The paper substrate used to form the microfluidic device can be selected so as to be flexible. For certain applications, the paper substrate can be selected to have a sufficient flexibility such that the paper substrate can be folded, creased, or otherwise mechanically shaped to impart structure and function to the paper-based device. Examples of suitable paper substrates for the fabrication of paper-based microfluidic devices include cellulose; derivatives of cellulose such as nitrocellulose or cellulose acetate; paper (e.g., filter paper, chromatography paper); woven cellulosic materials; and non-woven cellulosic materials.
In some embodiment, the paper substrate is paper. Paper is inexpensive, widely available, readily patterned, thin, lightweight, and can be disposed of with minimal environmental impact. Furthermore, a variety of grades of paper are available, permitting the selection of a paper substrate with the weight (i.e., grammage), thickness and/or rigidity and surface characteristics (i.e., porosity, hydrophobicity, and/or roughness), desired for the fabrication of a particular paper-based device. Suitable papers include, but are not limited to, chromatography paper, card stock, filter paper, vellum paper, printing paper, wrapping paper, ledger paper, bank paper, bond paper, blotting paper, drawing paper, fish paper, tissue paper, paper towel, wax paper, and photography paper.
As described above, the floor, the two or more side walls, and/or optionally the ceiling can be substantially hydrophobic, so as to form boundaries that restrict fluid flow within the hollow channel, thereby defining a path for the flow of an aqueous solution through the hollow channel. In the case of paper-based devices, regions of the paper substrate forming the floor, the two or more side walls, and/or optionally the ceiling can be rendered hydrophobic (i.e., hydrophobically modified) by treating the paper substrate with a hydrophobic agent. For example, the paper substrate may be covalently modified to comprise a hydrophobic agent, impregnated with a hydrophobic agent, and/or coated with a hydrophobic agent to render portions of the paper substrate hydrophobic. Suitable hydrophobic agents include, but are not limited to, curable polymers, natural waxes, synthetic waxes, polymerized photoresists, alkyl ketene dimers, alkenyl succinic anhydrides, hydrophobic halosilanes, rosins, silicones, fluorinated reagents, fluoropolymers, polyolefin emulsions, resin and fatty acids, or combinations thereof. The hydrophobic agent can be patterned using methods known in the art to form hydrophobic regions of defined dimensions on and/or within the paper substrate, as required for the design of a particular device.
One or more of the interior surfaces of the hollow channel (e.g., the floor, a side walls, the ceiling, or a combination thereof) can comprise a hydrophilic material. The hydrophilic material can be porous or non-porous. In some embodiments, the hydrophilic material can comprise a hydrophilic coating deposited on an otherwise hydrophobic surface (e.g., a surface of a hydrophobically modified paper substrate) that forms the floor, a side walls, and/or a ceiling of the hollow channel.
In some cases, the hydrophilic material can be a porous hydrophilic material. For example, the hydrophilic material can comprise a region of a paper substrate described above that forms the floor, a side walls, and/or a ceiling of the hollow channel, and that has not been hydrophobically modified. The porous hydrophilic material can form a hemichannel for fluid flow in fluid contact with the hollow channel. Fluid can be transported through the porous hydrophilic hemichannel by capillary action, thereby driving fluid flow along the adjacent hollow channel.
Example paper-based microfluidic devices including a hollow channel are schematically illustrated in
Referring again to
The channel layer (200) includes a hydrophobic boundary (206) defining a hollow channel (202) within the channel layer (200), for fluid flow within the second layer. The hydrophobic boundary (206) substantially permeates the thickness of the paper substrate, so as to form a boundary for fluid flow from the hollow channel to a region of the channel layer outside of the channel.
The hollow channel can be patterned within a channel layer formed from a paper substrate using any suitable method known in the art. For example, the channel can be patterned by wax printing. In these methods, an inkjet printer is used to pattern a wax material on the paper substrate. Many types of wax-based solid ink are commercially available and are useful in such methods as the ink provides a visual indication of the location of the hollow channel. However, it should be understood, that the wax material used to form the channel does not require an ink to be functional. Examples of wax materials that may be used include polyethylene waxes, hydrocarbon amide waxes or ester waxes. Once the wax is patterned, the paper substrate is heated (e.g., by placing the substrate on a hot plate with the wax side up at a temperature of 120° C.) and cooled to room temperature. This allows the wax material to substantially permeate the thickness of the paper substrate, so as to form a hydrophobic boundary that defines the dimensions of the hollow channel. The hollow channel can then be formed by removing the porous, cellulosic substrate within the hydrophobic boundary, thereby forming a void space through which a fluid can flow.
Referring again to
The example device can be assembled by aligning the three layers as shown in
Fluid flow through the hollow channel can be driven by a combination of pressure applied to the fluid inlet and/or fluid outlet, capillary flow through and/or along the hydrophilic material, and the hydrophobicity of the interior surfaces of the hollow channel. In some embodiments, fluid flow in the hollow channel is driven by capillary flow through and/or along a hydrophilic material present in the fabricated into a portion of the periphery of the hollow channel. In some embodiments, the hollow channel can be configured such that water can flow from the fluid inlet through the hollow channel to the fluid outlet under low applied pressure to fluid introduced at the fluid inlet (e.g., at an applied pressure 0.2 bar or less, at an applied pressure of 0.1 bar or less, at an applied pressure of 0.05 bar or less, or at an applied pressure of 0.01 bar or less). In some embodiments, fluid can flow from the fluid inlet through the hollow channel to the fluid outlet without the aid of pressure applied by an external pump (e.g., a syringe pump) and/or a column of fluid positioned to applied pressure at the fluid inlet.
The microfluidic devices described herein can optionally comprise one or more additional elements, as required to provide a device with suitable functionality for a particular application. For example, the microfluidic device can optionally comprise one or more additional layers, such as a slip layer. The slip layer can configured such that actuation of the slip layer can slow or stop the flow of a fluid through the hollow channel. The slip layer can configured such that actuation of the slip layer can introduce an assay reagent, discussed in more detail below, into contact with a fluid flowing through the hollow channel. A slip layer may be disposed between the sample deposition layer and the channel layer and/or between the channel layer and the base layer.
In some embodiments, the microfluidic device can further comprise an assay reagent to aid in detection and/or quantification of an analyte present in a fluid sample flowing through the hollow channel. By way of example, the analyte can be a molecule of interest present in a fluid sample that is introduced into the channel. The analyte can be, for example, an antibody, peptide (natural, modified, or chemically synthesized), protein (e.g., a glycoprotein, a lipoprotein, or a recombinant protein), polynucleotide (e.g, DNA or RNA, an oligonucleotide, an aptamer, or a DNAzyme), lipid, polysaccharide, small molecule organic compound (e.g., a hormone, a prohormone, a narcotic, or a small molecule pharmaceutical), pathogen (e.g., bacteria, virus, or fungi, or protozoa), or combination thereof.
The fluid sample can be a bodily fluid. “Bodily fluid”, as used herein, refers to a fluid composition obtained from or located within a human or animal subject. Bodily fluids include, but are not limited to, urine, whole blood, blood plasma, serum, tears, semen, saliva, sputum, exhaled breath, nasal secretions, pharyngeal exudates, bronchoalveolar lavage, tracheal aspirations, interstitial fluid, lymph fluid, meningal fluid, amniotic fluid, glandular fluid, feces, perspiration, mucous, vaginal or urethral secretion, cerebrospinal fluid, and transdermal exudate. Bodily fluid also includes experimentally separated fractions of all of the preceding solutions, as well as mixtures containing homogenized solid material, such as feces, tissues, and biopsy samples. The molecule of interest can be, for example, a biomarker (i.e., a molecular indicator associated with a particular pathological or physiological state) present in the bodily fluid that can be assayed to identify risk for, diagnosis of, or progression of a pathological or physiological process in a subject. Examples of biomarkers include proteins, hormones, prohormones, lipids, carbohydrates, DNA, RNA, and combinations thereof.
The assay reagent can include a molecule or matrix that can selectively associate with the analyte. The term “selectively associates”, as used herein when referring to an assay reagent, refers to a binding reaction which is determinative for the analyte in a heterogeneous population of other similar compounds. Generally, the interaction is dependent upon the presence of a particular structure (e.g., an antigenic determinant or epitope) on the binding partner. By way of example, an antibody or antibody fragment selectively associates to its particular target (e.g., an antibody specifically binds to an antigen) but it does not bind in a significant amount to other proteins present in the sample or to other proteins to which the antibody may come in contact in an organism. Examples of such molecules include antibodies, antibody fragments, antibody mimetics (e.g., engineered affinity ligands such as AFFIBODY® affinity ligands), peptides (natural or modified peptides), proteins (e.g., recombinant proteins, host proteins), polynucleotides (e.g, DNA or RNA, oligonucleotides, aptamers, or DNAzymes), receptors, ligands, antigens, organic small molecules (e.g., antigen or enzymatic co-factors), and combinations thereof. In some embodiments, the assay reagent can include a probe selected to facilitate radiological, magnetic, optical, and/or electrical measurements used to identify and/or quantify one or more analytes in a liquid sample. For example, the assay reagent can include a colorimetric probe, a fluorescent probe, a probe to facilitate electrochemical detection and/or quantification of an analyte, or combinations thereof, as discussed in more detail below.
The assay reagent can be positioned in fluid contact with the hollow channel, such that, as fluid migrates through the flow path of the hollow channel toward the fluid outlet, the assay reagent contacts the analyte. The assay reagent can also be deposited, for example on the fluid inlet and/or fluid outlet of the device, and/or at one or more assay regions in fluid contact with the fluid flow path. Assay reagents can be deposited in discrete areas, using e.g. a micro-arraying tool, ink jet printer, spray, pin-based contact printing or screen-printing method.
In some embodiments, the microfluidic device may contain one or more assay regions containing one or more assay reagents selected so as to provide a response in the presence of an analyte that is visible to the naked eye. In some cases, the assay reagent can be an indicator that exhibits colorimetric and/or fluorometric response in the presence of the analyte of interest. Indicators may include molecules that become colored in the presence of the analyte, change color in the presence of the analyte, or emit fluorescence, phosphorescence, or luminescence in the presence of the analyte. In these embodiments, the presence of an analyte may be ascertained by simple visual examination, optionally under a blacklight. In some cases, the quantity of one or more analytes may be determined by visual inspection of the color or fluorescence of an assay region, for example, by comparison to known colors at predetermined analyte concentrations.
Alternatively, the devices described herein can include a detection device that can evaluate the fluid sample and/or the assay reagent to indicate, for example, the presence, identity, or quantity of an analyte in a fluid sample. For example, a microfluidic device may contain one or more fluid outlets that connect the device to one or more external instruments, such as a mass spectrometer, fluorometer, LTV-Vis spectrometer, IR spectrometer, gas chromatograph, gel permeation chromatograph, DNA sequencer, Coulter counter, or combinations thereof, that can be used to analyze the fluid sample processed by the device. The microfluidic device can optionally be configured such that the fluid sample and/or assay reagent can be interrogated using a portable device, such as a digital camera, flatbed scanner, or cellular phone.
In certain embodiments, detection and/or quantification of the analyte can be accomplished using electrochemical methods. In some embodiments, the microfluidic device can comprise an electrode in electrochemical contact with the hollow channel, meaning that the electrode can participate in a faradaic reaction with one or more components of a fluid present in the hollow channel of the microfluidic device. For example, the electrode can be configured such that a surface of the electrode is in direct contact with fluid present in the hollow channel of the microfluidic device. The device can be configured such that the electrode can function as an anode, cathode, or anode and cathode during device operation.
The electrode can be configured to provide detection of an analyte or molecule of interest. For example, the device can include a three electrode system comprising a working electrode (analyte working electrode), a counter electrode, and a reference electrode (either a conventional reference electrode or a pseudo reference electrode). All three electrodes can be positioned in electrochemical contact with a region of the hollow channel within the microfluidic device.
Electrodes can be fabricated from any suitable conductive material, such as a metal (e.g., gold, platinum, or titanium), metal alloy, metal oxide, conducting polymer (e.g., PEDOT or PANI), or conductive carbon. The electrodes can be, for example, screen printed electrodes formed using a conductive ink. In certain embodiments, the electrode can be a bulk electrode. The bulk electrode can have a variety of 3-dimensional shapes, provided that the electrode can be integrated into the device, and is compatible with the formation of an electric field gradient suitable to direct ions flowing through the device. In certain embodiments, the bulk electrode is a bulk conductive electrode. Suitable bulk conductive electrodes include, but are not limited to wire, mesh, fiber, plate, foil, perforated plate, and perforated foil metal electrodes.
The devices described herein can be coupled to a power supply and optionally to one or more additional suitable features including, but not limited to, a voltmeter, an ammeter, a multimeter, an ohmmeter, a signal generator, a pulse generator, an oscilloscope, a frequency counter, a potentiostat, or a capacitance meter. The devices described herein can also be coupled to a computing device that performs arithmetic and logic operations necessary to process the electrochemical signals produced by the device (e.g., to determine analyte concentration, etc.).
The devices described herein can optionally further comprise structures that influence fluid flow through the hollow channel, manipulate the fluid sample as it flows through the hollow channel, and/or enhance or make more frequent the contact of analytes in solution with an assay reagent. For example, the device can include one or more obstacles disposed in the hollow channel to slow or stop the flow of a fluid through the hollow channel. Examples of suitable obstacles include pillars, beads, paper barriers, hydrophobic weirs, and combinations thereof. In some embodiments, the structures can be stimuli responsive. For example, the structures can be chemically or photonically responsive. In some embodiments, the structure can be a barrier that is present in the device when a fluid sample is first introduced into the device, but is removed at a later point upon application of a stimulus. For example, the structure can be a barrier that is present in the device when a fluid sample is first introduced into the device, but that dissolves at a later point (e.g., a photonically activated barrier that depolymerizes upon incident light, or a chemically activated barrier that reacts and/or dissolves upon contact with a particular chemical).
The microfluidic device can comprise a plurality of hollow channel. For example, for determining multiple analytes, the device may contain a plurality of hollow channels that can be used to process a fluid sample. These may be arranged in parallel or in any other convenient manner. Each of the plurality of hollow channels can contain an assay reagent for different analyte of interest. By way of example,
If desired, the devices described herein can be affixed to or secured within a polymer, metal, glass, wood, or paper support structure to facilitate handling and use of the device. In some embodiments, the devices described herein are affixed to or secured within an inert, non-absorbent polymer such as polydimethylsiloxane (PDMS), a polyether block amide (e.g., PEBAX®, commercially available from Arkema, Colombes, France), a polyacrylate, a polymethacrylate (e.g., poly(methyl methacrylate)), a polyimide, polyurethane, polyamide (e.g., Nylon 6,6), polyvinylchloride, polyester, (HYTREL®, commercially available from DuPont, Wilmington, Del.), polyethylene (PE), polyether ether ketone (PEEK), fluoropolymers such as polytetrafluoroethylene (PTFE), perfluoroalkoxy, fluorinated ethylene propylene, or a blend or copolymer thereof. Silastic materials and silicon-based polymers can also be used.
Methods of Use
The devices described herein can be inexpensive, user friendly (e.g., they can employ electrochemical detection without any washing steps), sensitive, portable, robust, efficient, rapid, and can be used to detect low concentrations of analytes. As such, the devices are well suited for use in numerous analytical applications. For example, the devices described herein can be used in clinical and healthcare settings to detect and/or quantify biomarkers to identify risk for, diagnosis of, or progression of a pathological or physiological process in a subject. Examples of biomarkers include proteins, hormones, prohormones, lipids, carbohydrates, DNA, RNA, and combinations thereof.
The devices described herein can be used in POC applications to diagnose infections in a patient (e.g., by measuring serum antibody concentrations or detecting antigens). For example, the devices can be used for amperometric and potentiometric detection of glucose, lactate, uric acid, ascorbic acid, β-D-galactosidase, cholesterol, Pb2+, H2O2, and cancer markers. In some embodiments, the devices described herein can be used to diagnose viral infections (e.g., HIV, hepatitis B, hepatitis C, rotavirus, influenza, polio, measles, yellow fever, rabies, dengue, or West Nile Virus), bacterial infections (e.g., E. coli, C. tetani, cholera, typhoid, diphtheria, tuberculosis, plague, Lyme disease, or H. pylori), and parasitic infections (e.g., toxoplasmosis, Chagas disease, or malaria). The devices described herein can be used to rapidly assesses the immune status of people or animals against selected vaccine-preventable diseases (e.g. anthrax, human papillomavirus (HPV), diphtheria, hepatitis A, hepatitis B, haemophilus influenzae type b (Hib), influenza (flu), Japanese encephalitis (JE), measles, meningococcal, mumps, pertussis, pneumococcal, polio, rabies, rotavirus, rubella, shingles (herpes zoster), smallpox, tetanus, typhoid, tuberculosis (TB), varicella (chickenpox), yellow fever). The devices described herein can be used to rapidly screen donated blood for evidence of viral contamination by HIV, hepatitis C, hepatitis B, and HTLV-1 and -2. The devices described herein can also be used to measure hormone levels. For example, the devices and methods described herein can be used to measure levels of human chorionic gonadotropin (hCG) (as a test for pregnancy), Luteinizing Hormone (LH) (to determine the time of ovulation), or Thyroid Stimulating Hormone (TSH) (to assess thyroid function). The devices described herein can be used to diagnose or monitor diabetes in a patient, for example, by measuring levels of glycosylated hemoglobin, insulin, or combinations thereof. The devices and methods described herein can be used to detect protein modifications (e.g., based on a differential charge between the native and modified protein and/or by utilizing recognition elements specific for either the native or modified protein). The devices described herein can be used to administer personalized medical therapies to a subject (e.g., in a pharmacogenomic assay performed to select a therapy to be administered to a subject). The devices can also be used to monitor the vascular endothelial growth factor (VEGF) levels in the urine of infants, e.g., premature infants. A conventional method of diagnosing retinal disease in premature infants is weekly or biweekly 15 minute examinations by an infant-retinal ophthalmologist, which is both expensive and disruptive to the infant. Detecting VEGF and other growth factors (such as IGF-1, or insulin-like growth factor 1) in urine can be useful for diagnosing retinopathy of prematurity, diabetes, cancer, and transplantation.
In other embodiments, the device can be used to analyze cerebrospinal fluid (CSF), for example to determine whether a patient has meningitis. In some embodiments, the devices can be used for breast milk analysis, e.g., to determine protein, fat, and glucose levels in the breast milk. In other embodiments, the devices can be used in tissue engineering applications, to monitor the output of small numbers of cells, e.g., measuring albumin output from small cultures of hepatocytes. Catalytic chemistries, such as ELISA, can be incorporated into the devices in order to make measurements of relatively small specimens. In still other embodiments, the devices can be used in ophthalmology, e.g., in analyzing components in the vitreous fluid (the contents of the eye) or in tear films.
The devices described herein can also be used in other commercial applications. For example, the devices described herein can be used in the food and beverage industry, for example, in quality control applications or to detect potential food allergens, such as milk, peanuts, walnuts, almonds, and eggs. The devices described herein can be used to detect and/or measure the levels of proteins of interest in foods, cosmetics, nutraceuticals, pharmaceuticals, and other consumer products. The devices described herein can also be used to rapidly and accurately detect narcotics and biothreat agents (e.g., ricin).
The examples below are intended to further illustrate certain aspects of the systems and methods described herein, and are not intended to limit the scope of the claims.
The following examples are set forth below to illustrate the methods and results according to the disclosed subject matter. These examples are not intended to be inclusive of all aspects of the subject matter disclosed herein, but rather to illustrate representative methods and results. These examples are not intended to exclude equivalents and variations of the present invention which are apparent to one skilled in the art.
Efforts have been made to ensure accuracy with respect to numbers (e.g., amounts, temperature, etc.) but some errors and deviations should be accounted for. Unless indicated otherwise, parts are parts by weight, temperature is in ° C. or is at ambient temperature, and pressure is at or near atmospheric. There are numerous variations and combinations of reaction conditions, e.g., component concentrations, temperatures, pressures and other reaction ranges and conditions that can be used to optimize the product purity and yield obtained from the described process.
A microfluidic paper analytical device (μPAD) that relies on flow in hollow channels (HC) to transport fluids was fabricated. The flow rate of a solution in the hollow channel is enhanced by up to a factor of 7 relative to fluid flow rate through a paper-filed channel of the same dimensions. The HC-PAD does not require external equipment, such as a syringe pump, to force the liquid into the channel. The high flow rate of the liquid reduces analysis times and also makes it possible to use large fluidic networks. The microfluidic device can multiplex numerous assays without being compromised by the speed of fluid flow.
Materials and Methods
Chemicals and Materials.
Erioglaucine disodium salt was purchased from Acros Organics. Phosphate-buffered saline (PBS), 10× solution, 30% HCl, and Whatman grade 1 chromatographic paper were obtained from Fisher Scientific. Glucose oxidase (GOx) from Aspergillus niger (type X-S), peroxidase from horseradish (type VI) (HRP), D-(+)-glucose (referred to as glucose), and albumin from bovine serum (BSA) were purchase from Sigma-Aldrich. Tetrabromophenol blue was obtained from Alfa Aesar. Sodium citrate was provided by EM Science. KI was obtained from Mallinckrodt Specialty Chemicals Co., and ethanol (99.5%) was purchased from Pharmaco-Aaper. All solutions were prepared using deionized water (18.2 MΩ·cm, Milli-Q Gradient System, Millipore). All reagents were used as received without further purification.
Device Fabrication.
The PADs were fabricated using a previously reported wax patterning method (Lu, Y. et al., Electrophoresis 2009, 30, 1497-500; Carrilho, E. et al., Anal. Chem. 2009, 81, 7091-7095). The devices were designed using CorelDraw12 software, and the specific patterns used for the different paper devices are shown in
Glucose and BSA Assays.
For the glucose and BSA assays, the reagents were dried in paper reservoirs defined on the top layer of the device. Finally, the PAD was folded according to the origami technique and tightly pressed together using two rigid 5 mm thick-polycarbonate pieces clamped with binder clips.
The glucose assay was prepared as follows. First, 1.0 μL of 0.86 M KI was drop casted into the paper wells. Second, after the KI solution was dried, 1.0 μL of a horseradish peroxidase/glucose oxidase solution (20/100 units) in PBS solution 1× (12 mM phosphate buffer, pH 7.4, 137 mM NaCl, and 2.7 mM KCl) was added to the wells. The BSA assay was prepared by drying 0.5 μL of a 250 mM citrate solution (sodium citrate solution acidified with concd HCl, pH 1.7) into each well, followed by addition of 0.5 μL of 3.3 mM tetrabromophenol blue in 95% ethanol. The solutions were dried at 20° C. under N2. The glucose standards were prepared by diluting a glucose stock solution in PBS 1× buffer. The glucose stock solution was prepared 1 day before the experiment to allow the glucose to mutarotate. The BSA standards were also prepared in PBS 1× buffer. An once scanner (HP C6180) was used to acquire optical images of the paper devices, and ImageJ freeware (NIH, Bethesda, Md.) was used to analyze the colors. For the glucose assay, the color pictures were converted to grayscale, and then the average intensity was correlated to the concentration of glucose. For the BSA assay, each pixel of the picture was split into red, green, and blue color spaces. The color intensity of the red channel was correlated with the concentration of BSA.
Results and Discussion
Fast Liquid Transport in Hollow Channels.
The flow rate of an aqueous solution of a blue dye in a hollow channel as a function of time and pressure using the configuration shown in
P=ρ×g×h (1)
at 20° C., g is the gravitational constant, and h is the height of the liquid in the inlet reservoir. To fully evaluate the performance of hollow channels, control experiments with paper channels were also carried out.
The effect of the pressure on the flow rate is shown
Although the high flow rates observed in hollow channels are primarily driven by pressure, capillary flow may also be important depending on the degree of hydrophobicity of the channel walls. In the absence of a hydrophilic floor, aqueous solutions do not enter inside the hollow channel over the pressure range represented in
As alluded to by the results presented thus far, the flow of liquids in hollow channels can be conveniently controlled by adjusting pressure and capillary forces. Indeed, in the absence of obstacles within the hollow channel, the liquid quickly reaches the outlet of the device and continues to flow until the inlet reservoir is empty. However, if there is a paper barrier within the hollow channel, the associated flow resistance can slow down the liquid, or stop it entirely, depending on the length of the barrier and the pressure at the inlet. For example, a 180 μm-long paper barrier placed at the inlet decreases the flow rate by a factor of 2 (compared to a barrier-free channel) under the influence of a 1.2 mbar pressure at the inlet. However, a 1 cm-long paper barrier completely stops the pressure-driven flow, leaving only the hydrophilic floor wet. Moreover, a 1 mm wide-hydrophobic wax line perpendicular to the hollow channel completely stops the liquid. The important point is that, in analogy to constrictions within other types of microfluidic devices, wax lines and paper barriers can be used to control flow rates from between 0 and several mm/s. Photographs of the devices showing the precise location of the barriers used for the aforementioned experiments are provided in
Colorimetric Detection of Glucose and BSA.
To demonstrate the potential of hollow channels for carrying out simple assays, glucose and BSA colorimetric reactions were used. The multiplexed assay was carried out using the 3D PAD design shown in
A photograph of the paper device 5 min after injection of a sample containing 20 mM of glucose and 75 μM of BSA is shown
For the PAD assay described in the previous paragraph, it takes about 0.5 min for the sample to flow from the inlet to the reaction wells. For the 5 min total assay time, this leaves 4.5 min to develop the color in the test zones. For a paper device having a similar design, but paper rather than hollow channels, it takes ˜2 min for the sample to reach the test zones. Thus, while sample transport accounts for only 10% of the total assay time in the hollow-channel PAD, it consumes 40% of the assay time in a paper channel. Note that the more complex or multiplexed the assay, the more advantage there is to the hollow channels. Additionally, the larger-than-usual footprint of the PAD used for the glucose and BSA assays (3.4×2.0 cm) is easier to handle than smaller paper-channel-based PADs, which is an important point for some POC applications.
Summary
Hollow channels enable fluid transport in paper-based devices up to 7 times faster than in cellulose-containing channels. The results indicate that flow is induced by a single drop of sample, thereby avoiding the need for pumping equipment. The flow rate within the hollow channels can be controlled by inserting hydrophobic weirs or short cellulose sections. Paper-based PADs having cellulose channels for DNA assays showed moderate to severe NSA even in the presence of blockers, a problem largely avoided by using hollow channels.
This example analyses electrochemical and fluidic processes in paper-based analytical devices (PADs) having hollow channels (HC-PADs). The HC-PADs exhibit electrochemical and hydrodynamic behavior similar to traditional glass and plastic microfluidic electrochemical devices. Removal of the cellulose fibers from the channels results in rapid mass transfer. The flow rate within the channel was quantified by electrochemical methods for pressures ranging from 0.3 mbar to 4.5 mbar. Voltammetry and amperometry were applied under flow and no-flow conditions and yielded reproducible electrochemical signals that can be described by classical electrochemical theory as well as finite-element simulations. The results shown here provide new and highly quantitative insights into the mass transfer and electrochemical properties of HC-PADs.
Materials and Methods
Chemicals and Materials.
Ferrocenemethanol (FcMeOH), and 1,1′-ferrocenedimethanol (FcDM) were purchased from Sigma-Aldrich (St. Louis, Mo.). Whatman grade 1 chromatography paper (20 cm×20 cm sheets), NaCl, and concentrated pH 7.4 phosphate buffered saline solution (PBS 10×, 119 mM phosphate, 1.37 M NaCl and 27 mM KCl) were purchased from Fisher Scientific (Waltham, Mass.). Tris(1,10-phenanthroline) iron(II) sulfate (Fe(phen)3SO4) and resazurin were purchased from Acros Organics (Morris Plains, N.J.). Tartrazine was purchased from MP Biomedicals LLC (Solon, Ohio). 4′,6-diamidino-2-phenylindole, dihydrochloride (DAPI) was purchased from Life Technologies (Carlsbad, Calif.). The carbon (CI-2042) and Ag(83%)/AgCl(17%) (CI-4002) inks were purchased from Engineered Conductive Materials (Delaware, Ohio). The solutions were prepared using deionized water (18.2 MΩ·cm, Milli-Q Gradient System, Millipore). All chemicals were used as received.
Device Fabrication.
The HC-PADs were fabricated using a previously reported wax patterning method (Renault, C. et al., Anal. Chem., 2013, 85, 7976-7979). The patterns were designed using CorelDraw12 software and printed on Whatman grade 1 chromatographic paper using a Xerox 8570DN inkjet wax printer. The patterns used for the different paper devices are shown in
The inks were then cured in an oven at 65° C. for 30 min. Channels and reservoirs larger than 2 mm were cut using a razor blade and a 4 mm-diameter punch (Harris Uni-core), while smaller HCs were cut using a laser cutter (Epilog Zing 16 from Epilog Laser, Golden, Colo. Parameters: Vector image, Speed: 90%, Power: 10%, Frequency: 1500 Hz). In all cases, clean cuts are required to avoid clogging the channels. After cutting the channels, the paper was folded into the final device configuration, sandwiched between two rigid, 5 mm-thick poly(methyl methacrylate) holders, and then clamped with binder clips. Copper tape (3M) was used to establish contact between the screen-printed electrodes and the potentiostat.
Electrochemical Measurements.
Electrochemical measurements were carried out at room temperature (23±1° C.) using a potentiostat (650 C, CH Instruments, Austin, Tex.) or bipotentiostat (700 E, CH Instruments, Austin, Tex.). In some cases a Pt wire counter electrode and a reference electrode (either a glass Ag/AgCl, 1 M KCl or a saturated calomel electrode (SCE), CH Instruments, Austin, Tex.) were placed into the outlet reservoir of the HC-PAD. The ohmic resistance in the HCs was electronically compensated (Rcomp).
Numerical Simulations.
Numerical simulations were performed using a Dell Precision T7500 Simulation workstation outfitted with Dual Six Core Intel Xeon Processors (2.40 GHz) and 24 GB of RAM. Simulations were carried out using the COMSOL Multiphysics v4.3 commercial package. All simulations were performed in 2D. Convective models solved the Navier-Stokes equation, assuming an incompressible fluid and no-slip boundary conditions on the floor and ceiling. Convection-diffusion simulations were performed assuming that the concentration of analyte was zero at the electrode surface, corresponding to the mass-transfer limited case.
Results and Discussion
Electrochemistry in Absence of Convection.
The first part of this study focuses on HC electrochemistry in the absence of convection. The configuration of the HC electrochemical cell is illustrated in
Cross-sectional micrographs of dry and wet HCs are compared in
The electrochemical behavior of the HC-PADs was characterized by cyclic voltammetry (CV) using FcMeOH as a redox probe. These experiments were carried out by flowing a solution containing 250 μM FcMeOH and PBS 1× through the HC for 5 min, stopping the flow, and then recording CVs at scan rates (v) between 10 and 100 mV/s (
The shape of the CVs in
In addition to cyclic voltammetry, chronoamperometry (CA) using the HC-PAD shown schematically in
To gain additional insight into the behavior of the CA at t>˜15 s, a numerical simulation of the CA experiment was obtained. For the simulation, the paper floor was modeled as an organized porous layer in which FcMeOH freely diffuses in the pores, but not through the solid cellulose fibers. The red line in
For poly(dimethylsiloxane) (PDMS) microchannels, it has previously been shown that constraint of the diffusion layer can affect the electrochemical response yielding, in extreme cases, a “thin layer” regime. Under the experimental conditions used here the current does not drop to zero as expected for an ideal thin layer electrochemical cell. The primary reason for this observation is that the diffusion layer continues to extend axially along the channel length (
Laminar Flow.
The nature of the flow regime within the channels of the HC-PADs is discussed below. To carry out these experiments, the HC-PAD design illustrated schematically in
Observation of the interior of the channel through the transparent plastic holder (
To confirm and quantify this result in the presence of the top wax layer supporting the electrodes (
The CVs shown in
Determination of Flow Rate.
To complete the characterization of flow in HC-PADs, the relationship between the flow rate and the pressure drop within the HC was investigated. The pressure drop (P) was controlled by adjusting the height difference (ΔH) between the columns of liquid in the inlet and outlet reservoirs (
The average linear flow rate (uav) was measured by electrochemistry using the generation-collection experiment depicted in
To compare the flow rate in HC-PADs with traditional PADs, a generation-collection experiment was conducted using a device identical to the HC-PAD, except that the cellulose fibers were left in the channel. The variation of uav with P in the paper-channel PAD was found to be 0.0056±0.0002 mm/(s mbar), or 480 times smaller than in HC PADs. This result simply illustrates that pressure-driven flow through a channel obstructed by cellulose fibers is much slower than through a HC.
The experimentally determined values of iLgen and iLcol (
The volumetric flow rate (Q) in HC-PADs was also measured by monitoring the variation of the liquid height in the outlet reservoir as a function of time (
The volumetric flow rate, Q, was measured using an optical method. A macroscope (Macroscope 8×30, RF Inter-Science Co., NY) was focused on the interface between the liquid, the air, and the wall of the plastic reservoir located at the outlet of the device (
Q=A u
av
where A is the cross-sectional area of the void part of the HC. A comparison of the experimental values of uav and Q can thus provide an estimate of the cross section of the device when operating. In this case, the apparent value of A is found to be 0.19±0.03 mm2. If the width of the channel is 2.0±0.2 mm, then the channel height, h, is only 95±25 μm; that is, ˜44±15% smaller than the value (h=170 μm) measured by microscopy.
Electrochemistry in the Presence of Convection.
The reproducibility and predictability of flow rates within HCs are ideal for coupling convection to electrochemical detection. In this subsection, the effect of the flow rate on the current is qualitatively and quantitatively analyzed using convection diffusion theories and numerical simulations.
A HC-PAD similar to the one presented in
When convection dominates, the current tends toward a constant, mass-transport-limited value, iL.
The calculated channel height (148 μm) was used with the other experimental parameters to carry out a numerical simulation of convection and diffusion in a HC. The experimentally determined value of uav (obtained from the fit in
The agreement between the experimental data and the simulation suggests that the approximations invoked for the simulations (the no-slip boundaries and the channel height) are reasonable.
Summary and Conclusions
HC-PADs provide reproducible, quantitative, and predictable electrochemical data. For example, in absence of convection two different regimes are observed: one for short times (<15 s), representing 1D semi-infinite diffusion, and a second case (>15 s), where the diffusion layer extends through the entire height of the channel. In the presence of convection, the electrochemical data are reproducible and quantitatively exhibit Levich behavior.
Fast pressure flow can be initiated using just a drop of fluid, and under the conditions described here flow is laminar and the average linear flow rate varies linearly with P from 0.8 mm/s to 12 mm/s. The flow in HC-PADs and plastic-based devices is similar.
Other advantages which are obvious and which are inherent to the invention will be evident to one skilled in the art. It will be understood that certain features and sub-combinations are of utility and may be employed without reference to other features and sub-combinations. This is contemplated by and is within the scope of the claims. Since many possible embodiments may be made of the invention without departing from the scope thereof, it is to be understood that all matter herein set forth or shown in the accompanying drawings is to be interpreted as illustrative and not in a limiting sense.
This application claims benefit of U.S. Provisional Application No. 61/953,469, filed Mar. 14, 2014, which is hereby incorporated herein by reference in its entirety.
This invention was made with government support under Contract No. HDTRA-1-13-1-0031 awarded by the Department of Defense/Defense Threat Reduction Agency (DTRA). The government has certain rights in this invention.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US15/20569 | 3/13/2015 | WO | 00 |